Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tranzyme Inc (TZYM) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tranzyme Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1274644.
Total stock buying since 2014: $381,405.
Total stock sales since 2014: $14,925.
Total stock option exercises since 2014: $26,091.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2017 | 3,000 | $3,854 | 0 | $0 | 0 | $0 |
| 2016 | 46,000 | $104,491 | 6,512 | $14,925 | 23,938 | $26,091 |
| 2015 | 50,050 | $186,673 | 0 | $0 | 0 | $0 |
| 2014 | 15,000 | $86,387 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2017-03 | 3,000 | $3,854 | 0 | $0 | 0 | $0 |
| 2016-12 | 7,000 | $14,980 | 0 | $0 | 0 | $0 |
| 2016-10 | 2,500 | $6,597 | 0 | $0 | 0 | $0 |
| 2016-09 | 0 | $0 | 6,512 | $14,925 | 0 | $0 |
| 2016-07 | 0 | $0 | 0 | $0 | 11,969 | $15,080 |
| 2016-03 | 3,000 | $9,570 | 0 | $0 | 0 | $0 |
| 2016-01 | 33,500 | $73,344 | 0 | $0 | 11,969 | $11,011 |
| 2015-06 | 5,000 | $18,550 | 0 | $0 | 0 | $0 |
| 2015-05 | 45,050 | $168,123 | 0 | $0 | 0 | $0 |
| 2014-10 | 2,000 | $9,620 | 0 | $0 | 0 | $0 |
| 2014-07 | 13,000 | $76,767 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-28 | Byrnes Michael (CFO and Treasurer) | Buy | 3,000 | 1.28 | 3,854 |
| 2016-12-07 | Grais Linda S (President and CEO) | Buy | 7,000 | 2.14 | 14,980 |
| 2016-10-13 | Bukofzer Stan (Chief Medical Officer) | Buy | 2,500 | 2.64 | 6,597 |
| 2016-09-12 | Powell Michael | Sale | 6,512 | 2.29 | 14,925 |
| 2016-07-11 | Powell Michael | Option Ex | 11,969 | 1.26 | 15,080 |
| 2016-03-04 | Grais Linda S (President and CEO) | Buy | 3,000 | 3.19 | 9,570 |
| 2016-01-22 | Grais Linda S (President and CEO) | Buy | 10,000 | 2.38 | 23,800 |
| 2016-01-15 | Byrnes Michael (CFO and Treasurer) | Buy | 3,500 | 2.07 | 7,244 |
| 2016-01-15 | Aggarwal Gaurav (Chief Business Officer) | Buy | 10,000 | 2.15 | 21,500 |
| 2016-01-15 | Grais Linda S (President and CEO) | Buy | 10,000 | 2.08 | 20,800 |
| 2016-01-04 | Weber Eckard | Option Ex | 11,969 | .92 | 11,011 |
| 2015-06-23 | Wierenga Wendall (Director) | Buy | 5,000 | 3.71 | 18,550 |
| 2015-05-07 | Patni Rajiv (Chief Development Officer) | Buy | 5,050 | 3.97 | 20,048 |
| 2015-05-06 | Byrnes Michael (CFO and Treasurer) | Buy | 2,500 | 3.61 | 9,025 |
| 2015-05-06 | Aggarwal Gaurav (Chief Business Officer) | Buy | 7,500 | 3.62 | 27,150 |
| 2015-05-06 | Grais Linda S (President and CEO) | Buy | 30,000 | 3.73 | 111,900 |
| 2014-10-01 | Byrnes Michael (VP, Finance & Treasurer) | Buy | 2,000 | 4.81 | 9,620 |
| 2014-07-11 | Grais Linda S (President and CEO) | Buy | 10,000 | 5.93 | 59,280 |
| 2014-07-11 | Tetlow Sharon (Acting CFO & Treasurer) | Buy | 3,000 | 5.83 | 17,487 |
Insider trading activities including stock purchases, stock sales, and option exercises of TZYM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tranzyme Inc (symbol TZYM, CIK number 1274644) see the Securities and Exchange Commission (SEC) website.